The Medicines Company (NASDAQ: MDCO) announced that it has entered into a definitive agreement to sell Cleviprex (clevidipine), Kengreal (cangrelor) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE